UNIVERSITY OF CALIFORNIA, SAN DIEGO
Spatially precise radio-chemo-immunotherapy using antibody conjugates
Spatially precise radio-chemo-immunotherapy using antibody conjugates is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN DIEGO, up to 533079, closing November 30, 2027.
Nov 30, 2027
(488d left)Overview
PROJECT SUMMARY/ABSTRACT Locally advanced cancers remain a therapeutic challenge to eradicate. The most successful treatments for such patients continue to combine decades old classical cytotoxic chemotherapies with radiotherapy. While chemo-radiotherapy improves tumor control, using non-targeted drugs increases…